US Stock MarketDetailed Quotes

VERA Vera Therapeutics

Watchlist
  • 43.820
  • +3.440+8.52%
Close Nov 1 16:00 ET
  • 43.820
  • 0.0000.00%
Post 20:01 ET
2.72BMarket Cap-20009P/E (TTM)

Vera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
69.97%37.34M
-0.47%31.11M
12.22%102.01M
-19.51%27.03M
-13.82%21.76M
45.91%21.97M
83.64%31.26M
164.24%90.9M
102.48%33.58M
248.10%25.24M
Selling and administrative expenses
39.95%8.03M
28.65%7.91M
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
83.84%21.91M
80.19%6.91M
51.52%5.59M
-General and administrative expense
39.95%8.03M
28.65%7.91M
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
83.84%21.91M
80.19%6.91M
51.52%5.59M
Research and development costs
80.59%29.31M
-7.60%23.2M
13.38%78.23M
-22.08%20.79M
-18.09%16.1M
60.51%16.23M
100.08%25.11M
206.85%68.99M
109.17%26.68M
451.52%19.66M
Operating profit
-69.97%-37.34M
0.47%-31.11M
-12.22%-102.01M
19.51%-27.03M
13.82%-21.76M
-45.91%-21.97M
-83.64%-31.26M
-164.24%-90.9M
-102.48%-33.58M
-248.10%-25.24M
Net non-operating interest income expense
140.91%3.19M
204.41%2.28M
453.17%4.19M
206.44%904K
189.29%1.22M
881.48%1.33M
914.13%749K
15,260.00%758K
2,207.14%295K
8,300.00%420K
Non-operating interest income
127.96%5.1M
157.92%4.19M
355.94%7.98M
119.24%1.96M
280.60%2.16M
751.33%2.24M
6,142.31%1.62M
11,566.67%1.75M
14,800.00%894K
11,240.00%567K
Non-operating interest expense
109.19%1.91M
118.08%1.91M
281.65%3.79M
76.29%1.06M
541.50%943K
614.06%914K
640.68%874K
4,860.00%992K
2,895.00%599K
--147K
Other net income (expense)
-8.28%443K
2.05%449K
67.89%1.83M
-44.58%470K
201.38%437K
600.00%483K
1,471.43%440K
-39.41%1.09M
443.32%848K
139.84%145K
Gain on sale of security
75.00%-7K
-300.00%-4K
94.19%-47K
96.88%-2K
92.57%-15K
89.06%-28K
99.65%-1K
9.30%-809K
74.09%-64K
44.51%-202K
Other non- operating income (expenses)
-11.94%450K
2.72%453K
-1.16%1.88M
-48.25%472K
30.26%452K
57.23%511K
40.00%441K
--1.9M
--912K
--347K
Income before tax
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.65M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.11%-89.06M
-92.56%-32.44M
-224.25%-24.68M
Income tax
0.00%1K
0.00%1K
Net income
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
Net income continuous Operations
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
Minority interest income
Net income attributable to the parent company
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
-173.10%-89.06M
-92.55%-32.44M
-224.25%-24.68M
Basic earnings per share
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
-37.86%-3.35
-50.63%-1.19
-152.78%-0.91
Diluted earnings per share
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
-37.86%-3.35
-50.63%-1.19
-152.78%-0.91
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 69.97%37.34M-0.47%31.11M12.22%102.01M-19.51%27.03M-13.82%21.76M45.91%21.97M83.64%31.26M164.24%90.9M102.48%33.58M248.10%25.24M
Selling and administrative expenses 39.95%8.03M28.65%7.91M8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M83.84%21.91M80.19%6.91M51.52%5.59M
-General and administrative expense 39.95%8.03M28.65%7.91M8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M83.84%21.91M80.19%6.91M51.52%5.59M
Research and development costs 80.59%29.31M-7.60%23.2M13.38%78.23M-22.08%20.79M-18.09%16.1M60.51%16.23M100.08%25.11M206.85%68.99M109.17%26.68M451.52%19.66M
Operating profit -69.97%-37.34M0.47%-31.11M-12.22%-102.01M19.51%-27.03M13.82%-21.76M-45.91%-21.97M-83.64%-31.26M-164.24%-90.9M-102.48%-33.58M-248.10%-25.24M
Net non-operating interest income expense 140.91%3.19M204.41%2.28M453.17%4.19M206.44%904K189.29%1.22M881.48%1.33M914.13%749K15,260.00%758K2,207.14%295K8,300.00%420K
Non-operating interest income 127.96%5.1M157.92%4.19M355.94%7.98M119.24%1.96M280.60%2.16M751.33%2.24M6,142.31%1.62M11,566.67%1.75M14,800.00%894K11,240.00%567K
Non-operating interest expense 109.19%1.91M118.08%1.91M281.65%3.79M76.29%1.06M541.50%943K614.06%914K640.68%874K4,860.00%992K2,895.00%599K--147K
Other net income (expense) -8.28%443K2.05%449K67.89%1.83M-44.58%470K201.38%437K600.00%483K1,471.43%440K-39.41%1.09M443.32%848K139.84%145K
Gain on sale of security 75.00%-7K-300.00%-4K94.19%-47K96.88%-2K92.57%-15K89.06%-28K99.65%-1K9.30%-809K74.09%-64K44.51%-202K
Other non- operating income (expenses) -11.94%450K2.72%453K-1.16%1.88M-48.25%472K30.26%452K57.23%511K40.00%441K--1.9M--912K--347K
Income before tax -67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.65M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.11%-89.06M-92.56%-32.44M-224.25%-24.68M
Income tax 0.00%1K0.00%1K
Net income -67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M
Net income continuous Operations -67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M
Minority interest income
Net income attributable to the parent company -67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M-173.10%-89.06M-92.55%-32.44M-224.25%-24.68M
Basic earnings per share -34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8-37.86%-3.35-50.63%-1.19-152.78%-0.91
Diluted earnings per share -34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8-37.86%-3.35-50.63%-1.19-152.78%-0.91
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data